Novavax Starts Phase IIb Trial of Covid-19 Vaccine in South Africa
US-based biotechnology company Novavax has launched a Phase IIb clinical trial of its Covid-19 vaccine candidate, NVX-CoV2373, in South Africa. The trial, conducted in partnership...
May 26, 2022
Trending now